Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01290549 |
|---|---|
| Brief Title: | A Study of Escalating Doses of Polatuzumab Vedotin in Participants With Relapsed or Refractory B-Cell Non-Hodgkins Lymphoma and Chronic Lymphocytic Leukemia and Polatuzumab Vedotin in Combination With Rituximab in Participants With Relapsed or Refractory B-Cell Non-Hodgkins Lymphoma |
| First Submitted : | February 3, 2011 |
| First Submitted that Met QC Criteria : | February 4, 2011 |
| First Posted : | February 7, 2011 (Estimate) |
| Last Update Submitted that Met QC Criteria : | June 14, 2017 |
| Last Update Posted : | June 16, 2017 |